Neobavaisoflavone, an isoflavanone derivative, has been reported to display an anti-fungal capacity in vitro. Studies show that this compound can also capable of inhibiting platelet aggregation in rabbit platelets induced by arachidonic acid in vitro. Additional experiments have noted Neobavaisoflavone to be a DNA polymerase inhibitor and an enhancer of TRIAL-induced apoptosis of cells. TRIAL (tumor necrosis factor-related apoptosis-inducing ligand) is an agent that selectively induces programmed cell death in certain cells.
1. Nkengfack, A.E., et al. 1994. Phytochemistry. 36: 1047-1051. PMID: 7765206
2. Tsai, W.J., et al. 1996. J. Nat. Prod. 59: 671-672. PMID: 8759164
3. Sun, N.J., et al. 1998. J. Nat. Prod. 61: 362-366. PMID: 9544566
4. Bronikowska, J., et al. 2010. Molecules. 15: 2000-2015. PMID: 20336028
La Santa Cruz Biotechnology, Inc. è un leader mondiale nello sviluppo di prodotti per il mercato della ricerca biomedica. Chiamaci al numero gratuito 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. Tutti i diritti riservati. "Santa Cruz Biotechnology", ed il logo Santa Cruz Biotechnology, Inc."Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", il logo San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", ed "EZ Touch" sono marchi registrati dalla Santa Cruz Biotechnology, Inc.
Tutti i marchi sono proprietà dei rispettivi proprietari.